Thank you for correcting the text in this article. Your corrections improve Papers Past searches for everyone. See the latest corrections.

This article contains searchable text which was automatically generated and may contain errors. Join the community and correct any errors you spot to help us improve Papers Past.

Article image
Article image
Article image
Article image

VALUABLE NEW DRUG

NOT A SECRET FORMULA AT DISPOSAL OF MEDICAL PROFESSION Press Association—By Telegraph—Copyright LONDON, January 29. In connection with Sir Graham Little’s statement in the House of Commons that mortality in cases of puerperal fever treated with the new drug m Queen Charlotte’s Hospital, London, had decreased from 22 to 2 per cent., he disclosed in an interview that the new drug was named sulphoriamide. It was only revealed to the London Pathological Society a fortnight ago, and is regarded as a great advance in the science of drugs, as it is similar in constitution and possesses less toxicity than many earlier drugs recommended for a similar purpose. There was also a tremendous advantage in that it could best be administered by the mouth. It is not a secret formula or patent, but is at the disposal of the medical profession. It is understood that part of the work on the discovery of the drug was done in England.

Permanent link to this item

https://paperspast.natlib.govt.nz/newspapers/ESD19370130.2.97

Bibliographic details

Evening Star, Issue 22560, 30 January 1937, Page 15

Word Count
161

VALUABLE NEW DRUG Evening Star, Issue 22560, 30 January 1937, Page 15

VALUABLE NEW DRUG Evening Star, Issue 22560, 30 January 1937, Page 15

Help

Log in or create a Papers Past website account

Use your Papers Past website account to correct newspaper text.

By creating and using this account you agree to our terms of use.

Log in with RealMe®

If you’ve used a RealMe login somewhere else, you can use it here too. If you don’t already have a username and password, just click Log in and you can choose to create one.


Log in again to continue your work

Your session has expired.

Log in again with RealMe®


Alert